Old Web
English
Sign In
Acemap
>
authorDetail
>
MaryAnn Lukas
MaryAnn Lukas
GlaxoSmithKline
Heart failure
Cardiology
Internal medicine
Medicine
Diabetes mellitus
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Meta-Analysis of Two Double-Blind, Placebo Controlled, Randomized Trials to Evaluate the Efficacy and Safety of Carvedilol Treatment in Non-Dialysis Dependent Chronic Kidney Disease Patients with Symptomatic or Asymptomatic Systolic Heart Failure
2009
Journal of Cardiac Failure
Ravinder K. Wali
Malini Iyengar
D. Chartyan
MaryAnn Lukas
Christopher J. Cooper
Alfred K. Cheung
Show All
Source
Cite
Save
Citations (0)
Results of A Multicenter, Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects with Stable Chronic Heart Failure (The COMPARE Trial) (10/7/08)
2008
Journal of Cardiac Failure
Barry H. Greenberg
Mandeep R. Mehra
John R. Teerlink
Edward M. Gilbert
MaryAnn Lukas
Show All
Source
Cite
Save
Citations (2)
821-1 Should beta-blockers be used before angiotensin converting enzyme inhibitors in patients with chronic heart failure? Meta-analysis of the prognostic benefit conferred by beta-blockers in patients not receiving ACE inhibitors
2004
Journal of the American College of Cardiology
Henry Krum
Steven Joseph Haas
Jalal K. Ghali
Edward M. Gilbert
Phillipe Lechat
MaryAnn Lukas
Milton Packer
Ellen B. Roecker
Patricia Verkenne
Hans Wedel
John Wikstrand
Show All
Source
Cite
Save
Citations (1)
1